How has Adaptive Biotechnologies's interest income and other, net changed year-over-year?

Adaptive Biotechnologies's interest income and other, net decreased by 22.4% year-over-year, from $2.68M to $2.08M.

What is the long-term trend for Adaptive Biotechnologies's interest income and other, net?

Over 4 years (2021 to 2025), Adaptive Biotechnologies's interest income and other, net has grown at a 54.3% compound annual growth rate (CAGR), from $1.67M to $9.44M.

Adaptive Biotechnologies ADPT Interest income and other, net

Interest income and other, net at other companies

Nurix Therapeutics, Inc.NRIX

——

Other financials

Income statement

See full

Revenue$70.9M+35.1%

Gross profit$52.2M+47.1%

Operating income-$19.2M+35.1%

Net income-$20.0M+32.9%

EPS (diluted)-$0.13+35.0%

Balance sheet

See full

Cash & equivalents$77.6M+53.2%

Total debt$208.2M-5.6%

Total equity$216.3M+13.6%

Total assets$505.9M-1.0%

Cash flow

See full

Operating cash flow-$9.5M+66.5%

CapEx$796.0K-36.8%

Free cash flow-$10.3M+65.3%

Valuation

See full

Market cap$2.76B+93.6%

Enterprise value$2.89B+78.0%

P/S9.3×+1.8×

Profitability

See full

Gross margin75.3%+12.7pp

Operating margin-15.8%-7.0pp

Net margin-16.8%-7.3pp

FCF margin-10.5%-4.6pp

Returns & leverage

See full

Return on equity-24.4%-9.2pp

Debt / equity1×-0.2×

Current ratio3.4×+0.4×

Where this comes from

Reported directly by Adaptive Biotechnologies in its filing.

Tagged under the XBRL concept us-gaap:InterestAndOtherIncome.

The official record: Adaptive Biotechnologies’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Adaptive Biotechnologies's interest income and other, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Adaptive Biotechnologies's interest income and other, net?: Adaptive Biotechnologies (ADPT) reported interest income and other, net of $2.08M in Q1 2026.
How has Adaptive Biotechnologies's interest income and other, net changed year-over-year?: Adaptive Biotechnologies's interest income and other, net decreased by 22.4% year-over-year, from $2.68M to $2.08M.
What is the long-term trend for Adaptive Biotechnologies's interest income and other, net?: Over 4 years (2021 to 2025), Adaptive Biotechnologies's interest income and other, net has grown at a 54.3% compound annual growth rate (CAGR), from $1.67M to $9.44M.